P1Z

4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE

Find entries where: P1Z

is present as a standalone ligand in 5 entries

Find related ligands:

Chemical Component Summary
Name	4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE
Identifiers	4-butyl-1,2-diphenyl-pyrazolidine-3,5-dione
Formula	C₁₉ H₂₀ N₂ O₂
Molecular Weight	308.374
Type	NON-POLYMER
Isomeric SMILES	CCCCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3
InChI	InChI=1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3
InChIKey	VYMDGNCVAMGZFE-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	43
Chiral Atom Count	0
Bond Count	45
Aromatic Bond Count	12

Drug Info: DrugBank

DrugBank ID	DB00812
Name	Phenylbutazone
Groups	vet_approved approved
Description	A drug that has anti-inflammatory, antipyretic, and analgesic activities. It is especially effective in the treatment of ankylosing spondylitis. It also is useful in rheumatoid arthritis and Reiter's syndrome (investigational indication). Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. (From AMA Drug Evaluations Annual, 1994, p1822)
Synonyms	4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione Phenylbutazone Phénylbutazone Phenylbutazon 4-butyl-1,2-diphenyl-pyrazolidine-3,5-dione Phenbutazone Phenylbutazonum 3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine Fenilbutazona
Brand Names	Alka Phenylbutazone Tab Novo-butazone Tab 100mg Apo Phenylbutazone Tab 100mg Phenylone Plus Tab Alka Phenyl Tab
Indication	For the treatment of backache and ankylosing spondylitis
Categories	Agents causing hyperkalemia Agents that produce hypertension Analgesics Analgesics, Non-Narcotic Anti-Inflammatory Agents Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal (Non-Selective) Antiinflammatory and Antirheumatic Products Antiinflammatory and Antirheumatic Products, Non-Steroids Antiinflammatory Preparations, Non-Steroids for Topical Use Antirheumatic Agents Butylpyrazolidines Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP3A Inducers Cytochrome P-450 CYP3A4 Inducers Cytochrome P-450 CYP3A4 Inducers (strength unknown) Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Musculo-Skeletal System Nephrotoxic agents Non COX-2 selective NSAIDS OAT1/SLC22A6 inhibitors OAT3/SLC22A8 Inhibitors Peripheral Nervous System Agents Pyrazoles Pyrazolones Sensory System Agents Topical Products for Joint and Muscular Pain
ATC-Code	M01BA01 M01AA01 M02AA01
CAS number	50-33-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Prostaglandin G/H synthase 1	MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFG...	unknown	inhibitor
Prostaglandin G/H synthase 2	MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...	unknown	inhibitor
Prostacyclin synthase	MAWAALLGLLAALLLLLLLSRRRTRRPGEPPLDLGSIPWLGYALDFGKDA...	unknown	inhibitor
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	inducer
Cytochrome P450 2C9	MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...	unknown	substrate,inhibitor
Solute carrier family 22 member 6	MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR...	unknown	inhibitor
Solute carrier family 22 member 8	MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCR...	unknown	inhibitor
Solute carrier family 22 member 11	MAFSKLLEQAGGVGLFQTLQVLTFILPCLMIPSQMLLENFSAAIPGHRCW...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682